Company Filing History:
Years Active: 1995
Title: The Innovations of Robert Wohl
Introduction
Robert Wohl is an accomplished inventor based in South Setauket, NY (US). He is known for his significant contributions to the field of biotechnology, particularly in the development of angiogenic peptides. His work has the potential to impact various medical applications, including wound healing and tissue repair.
Latest Patents
Wohl holds a patent for angiogenic peptides, which are related to platelet factor 4. This invention focuses on peptides and peptide derivatives that exhibit angiogenic activity. The patent describes pharmaceutical compositions that include these peptides and methods for promoting angiogenesis. The discovery highlights an octapeptide derived from platelet factor 4 and seven structurally related peptides capable of inducing an angiogenic response in vivo. This response is measured by neovascularization in rabbit corneal implant assays and capillary endothelial cell chemoattraction. The angiogenic peptides may be particularly useful in promoting wound healing, bone repair, burn healing, and post-infarction repair in myocardial injury.
Career Highlights
Robert Wohl is associated with Curative Technologies, Inc., where he continues to innovate in the field of biotechnology. His work is characterized by a commitment to advancing medical science through the development of novel therapeutic agents.
Collaborations
Wohl has collaborated with notable colleagues, including Russell B. Whitman and Ronald G. Duff. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Robert Wohl's contributions to the field of biotechnology, particularly through his patented angiogenic peptides, demonstrate his innovative spirit and dedication to improving medical treatments. His work holds promise for enhancing wound healing and tissue repair, making a significant impact in the medical community.